Materiały źródłowe

• #1 Chondrosarcoma – UpToDate

  https://www.uptodate.com/contents/chondrosarcoma

  Chondrosarcomas are a heterogeneous group of malignant bone tumors that all produce chondroid (cartilaginous) matrix. Chondrosarcomas are the third most common primary malignancy of bone after myeloma and osteosarcoma. They account for 20 to 27 percent of primary malignant osseous neoplasms. […] This clinical presentation, diagnosis, and management of chondrosarcoma is presented here. Chondrosarcomas involving the head and neck and skull base, as well as diagnosis and biopsy techniques for general bone tumors, are discussed separately. […] Histologic grade is one of the most important indicators of clinical behavior and prognosis. Conventional chondrosarcomas are graded on a scale from 1 to 3, based upon nuclear size, staining pattern (hyperchromasia), mitotic activity, and degree of cellularity.

• #2 Chondrosarcoma – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK538132/

  Chondrosarcomas are malignant cartilaginous neoplasms with diverse morphological features and clinical behavior. They account for about 20 percent of all primary malignant tumors of the bone and usually arise in the pelvis or long bones. Primary or conventional chondrosarcoma arises in preexisting normal bone and is distinguished from the rarer secondary tumors, which occur within a preexisting enchondroma or osteochondroma. […] The radiographic features of chondrosarcoma are often very characteristic, and a definitive diagnosis can usually be made by imaging examination alone. […] Tissue biopsy is essential to diagnose chondrosarcoma and differentiate it from other malignant or benign bone tumors. Biopsy should be taken from the most aggressive portion of cancer as determined by imaging. […] Correlation between gross, radiographic, and microscopic features of the lesion is crucial to establish the definitive diagnosis of chondrosarcoma.

• #3 Chondrosarcoma – Symptoms, Types, Causes & Diagnosis

  https://www.ganeshdiagnostic.com/blog/chondrosarcoma-cancer-symptoms-types-causes-and-diagnosis

  When cells mutate and multiply uncontrollably, develop cancer. A bone cancer called chondrosarcoma begins in cartilage cells. The second most frequent primary bone cancer in adults is chondrosarcoma. The pelvis, scapula, sternum, and ribs are the axial skeleton bones that are most frequently affected by chondrosarcoma. Chondrosarcoma must be diagnosed and distinguished from other malignant and benign bone tumors via tissue biopsy. Imaging should be used to pinpoint the most aggressive area of the malignancy for biopsy. The major treatment for chondrosarcoma is surgery. Chondrosarcoma grading is important and helpful in predicting histological behavior. The prognosis is based on how quickly the cancer is identified and treated. […] If you have been diagnosed with chondrosarcoma or exhibit any of its symptoms, you must contact a doctor. The prognosis can be improved and complications can be avoided with early detection and treatment.

• #4 Chondrosarcoma: A Clinical Review

  https://www.mdpi.com/2077-0383/12/7/2506

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability. Additionally, there is a high rate of biopsy sampling error, particular in pelvic-based lesions. The preoperative histologic grade should be taken into consideration alongside radiologic and clinical assessment in determining optimal management.

• #5 Chondrosarcoma: A Clinical Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10095313/

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability.

• #6 Chondrosarcoma: A Clinical Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10095313/

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability.

• #7 Chondrosarcoma – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK538132/

  Chondrosarcomas are malignant cartilaginous neoplasms with diverse morphological features and clinical behavior. They account for about 20 percent of all primary malignant tumors of the bone and usually arise in the pelvis or long bones. Primary or conventional chondrosarcoma arises in preexisting normal bone and is distinguished from the rarer secondary tumors, which occur within a preexisting enchondroma or osteochondroma. […] The radiographic features of chondrosarcoma are often very characteristic, and a definitive diagnosis can usually be made by imaging examination alone. […] Tissue biopsy is essential to diagnose chondrosarcoma and differentiate it from other malignant or benign bone tumors. Biopsy should be taken from the most aggressive portion of cancer as determined by imaging. […] Correlation between gross, radiographic, and microscopic features of the lesion is crucial to establish the definitive diagnosis of chondrosarcoma.

• #8 Chondrosarcoma: A Clinical Review

  https://www.mdpi.com/2077-0383/12/7/2506

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability. Additionally, there is a high rate of biopsy sampling error, particular in pelvic-based lesions. The preoperative histologic grade should be taken into consideration alongside radiologic and clinical assessment in determining optimal management.

• #9 Chondrosarcoma Diagnosis & Treatment – NYC | Columbia Neurosurgery in New York City

  https://www.neurosurgery.columbia.edu/patient-care/conditions/chondrosarcoma

  A chondrosarcoma is a malignant bone tumor. Chondrosarcomas arise from the cartilage-producing cells around bones. […] Chondrosarcomas of the spine usually cause bone pain that is not relieved by rest. […] Computed tomography (CT) scans are used to examine the bones of the spine. Magnetic resonance (MR) scans may also be used to distinguish the tumor from other sensitive structures in the area. A contrast agent may be injected before a CT or MRI so that neurosurgeons can better visualize the tumor against the normal structures in the background. […] Plain X-rays are not typically useful in visualizing chondrosarcomas. […] Spinal angiography, which reveals blood flow in the area around the tumor, may also be used. This imaging study can help direct the surgical approach to the tumor by showing which blood vessels are affected by the tumor.

• #10 Chondrosarcoma: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/22112-chondrosarcoma

  Chondrosarcomas are a group of rare bone cancer tumors that begin in your cartilage. […] The most common treatment is surgery to remove cancerous cartilage and bone. […] Overall, 79% of people with chondrosarcoma are alive five years after diagnosis. […] A healthcare provider will ask questions about your symptoms, including: When you first noticed them. […] Theyll do a physical examination and may order imaging tests or a biopsy. […] To diagnose chondrosarcomas, healthcare providers may order the following imaging tests: X-ray. […] Your provider may refer you to an orthopaedist, a surgeon who diagnoses and treats conditions including bone cancer, to do a biopsy. […] A pathologist will examine the tissue sample for signs of cancerous cells. If cells are cancerous, theyll identify the tumor type and establish a tumor grade.

• #11 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  Chondrosarcoma is a type of bone cancer that originates from cartilage cells and typically occurs in the bones of the limbs and the pelvis. However, it can also occur in the bones of the skull, spine, and other parts of the body. Chondrosarcoma of the brain and spine is a rare form of the disease. […] A proper medical evaluation is needed for a definitive diagnosis. […] Early detection and diagnosis are crucial for successful treatment and a positive outcome. […] Diagnosis of chondrosarcomas of the brain and spine typically involves a combination of medical examination, imaging tests, and biopsy. Some of the diagnostic steps that may be taken include: Medical history and physical examination: Your doctor will ask about your symptoms and medical history and will perform a physical examination to check for signs of a tumor or other abnormal growth. Imaging tests, such as X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI), or positron emission tomography (PET) scans, can help your doctor to identify a tumor and determine its size, location, and shape. A biopsy is a procedure in which a small sample of tissue is removed from the tumor for examination under a microscope. This can help to confirm the diagnosis of chondrosarcoma and to determine the grade of the tumor.

• #12 Chondrosarcoma – Wikipedia

  https://en.wikipedia.org/wiki/Chondrosarcoma

  Imaging studies including radiographs („x-rays”), computerized tomography (CT), and magnetic resonance imaging (MRI) are often used to make a presumptive diagnosis of chondrosarcoma. However, a definitive diagnosis depends on the identification of malignant cancer cells producing cartilage in a biopsy specimen that has been examined by a pathologist. […] There are no blood tests currently available to enable an oncologist to render a diagnosis of chondrosarcoma. The most characteristic imaging findings are usually obtained with CT. […] Nearly all chondrosarcoma patients appear to be in good health. Often, patients are not aware of the growing tumor until there is a noticeable lump or pain. Earlier diagnosis is generally accidental when a patient undergoes testing for another problem and physicians discover cancer. Occasionally the first symptom will be a broken bone at the cancerous site. Any broken bone that occurs from mild trauma warrants further investigation, although there are many conditions that can lead to weak bones, and this form of cancer is not a common cause of such breaks.

• #13 Chondrosarcoma – Wikipedia

  https://en.wikipedia.org/wiki/Chondrosarcoma

  Imaging studies including radiographs („x-rays”), computerized tomography (CT), and magnetic resonance imaging (MRI) are often used to make a presumptive diagnosis of chondrosarcoma. However, a definitive diagnosis depends on the identification of malignant cancer cells producing cartilage in a biopsy specimen that has been examined by a pathologist. […] There are no blood tests currently available to enable an oncologist to render a diagnosis of chondrosarcoma. The most characteristic imaging findings are usually obtained with CT. […] Nearly all chondrosarcoma patients appear to be in good health. Often, patients are not aware of the growing tumor until there is a noticeable lump or pain. Earlier diagnosis is generally accidental when a patient undergoes testing for another problem and physicians discover cancer. Occasionally the first symptom will be a broken bone at the cancerous site. Any broken bone that occurs from mild trauma warrants further investigation, although there are many conditions that can lead to weak bones, and this form of cancer is not a common cause of such breaks.

• #14 The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis | Journal of Orthopaedic Surgery and Research | Full Text

  https://josr-online.biomedcentral.com/articles/10.1186/s13018-020-01748-w

  Although chondrosarcoma normally presents with increased pain, these symptoms and signs can be nonspecific and lead to a misdiagnosis of other musculoskeletal disorders such as osteomyelitis and osteoarthritis. […] 18F-fluorodeoxyglucose (18F-FDG) avidity provides useful information regarding tumor biology and sarcomatous transformation by depicting glucose metabolism and identifying hypermetabolic foci. […] A series of studies have investigated the utility of 18F-FDG PET or PET/CT in the diagnosis and staging of chondrosarcoma and revealed contradictory conclusions. […] The current investigation aimed to further assess the ability of 18F-FDG PET and PET/CT to diagnose chondrosarcoma and to predict the histological grade by performing a meta-analysis. […] The pooled sensitivity and specificity of 18F-FDG PET for diagnosing chondrosarcoma were 0.84 (95% CI, 0.46 to 0.97) and 0.82 (95% CI, 0.55 to 0.94), respectively.

• #15 Chondrosarcoma: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/22112-chondrosarcoma

  Chondrosarcomas are a group of rare bone cancer tumors that begin in your cartilage. […] The most common treatment is surgery to remove cancerous cartilage and bone. […] Overall, 79% of people with chondrosarcoma are alive five years after diagnosis. […] A healthcare provider will ask questions about your symptoms, including: When you first noticed them. […] Theyll do a physical examination and may order imaging tests or a biopsy. […] To diagnose chondrosarcomas, healthcare providers may order the following imaging tests: X-ray. […] Your provider may refer you to an orthopaedist, a surgeon who diagnoses and treats conditions including bone cancer, to do a biopsy. […] A pathologist will examine the tissue sample for signs of cancerous cells. If cells are cancerous, theyll identify the tumor type and establish a tumor grade.

• #16 Chondrosarcoma Causes, Symptoms, and Treatments

  https://www.upmc.com/services/orthopaedics/conditions/chondrosarcoma

  How Do You Diagnose Chondrosarcoma? […] Chondrosarcoma is a rare disease. Your care team may include orthopaedic surgeons and oncologists with specialized knowledge of bone cancer. […] What to expect during your visit […] Your doctor will take your medical history and ask you questions about your overall health and any symptoms youre experiencing. They’ll ask if there’s any history of cancer in your family or if you have any inherited conditions that could be risk factors for chondrosarcoma. […] Your doctor will perform a physical exam, focusing on the areas causing pain. […] Tests to diagnose chondrosarcoma […] Your doctor will start by ordering x-rays to view images of your bones. […] Then, they may order the following tests to diagnose chondrosarcoma: […] A biopsy. Doctors will remove a small piece of tissue from the tumor and look at it under a microscope. They’ll be able to confirm where the tumor started, and what grade it is. […]

• #17 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  Chondrosarcoma is a type of bone cancer that originates from cartilage cells and typically occurs in the bones of the limbs and the pelvis. However, it can also occur in the bones of the skull, spine, and other parts of the body. Chondrosarcoma of the brain and spine is a rare form of the disease. […] A proper medical evaluation is needed for a definitive diagnosis. […] Early detection and diagnosis are crucial for successful treatment and a positive outcome. […] Diagnosis of chondrosarcomas of the brain and spine typically involves a combination of medical examination, imaging tests, and biopsy. Some of the diagnostic steps that may be taken include: Medical history and physical examination: Your doctor will ask about your symptoms and medical history and will perform a physical examination to check for signs of a tumor or other abnormal growth. Imaging tests, such as X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI), or positron emission tomography (PET) scans, can help your doctor to identify a tumor and determine its size, location, and shape. A biopsy is a procedure in which a small sample of tissue is removed from the tumor for examination under a microscope. This can help to confirm the diagnosis of chondrosarcoma and to determine the grade of the tumor.

• #18 Chondrosarcoma Treatment in Delhi, India | Symptoms & Causes

  https://www.blkmaxhospital.com/our-specialities/sarcoma-and-bone-cancer-program/conditions-treatments/chondrosarcoma

  When it comes to diagnosing chondrosarcoma, healthcare professionals employ various methods to accurately detect and confirm the presence of this rare type of cancer. These diagnostic tools include physical exams, imaging tests, and biopsy procedures. Let’s delve into each of these methods in more detail. […] During a physical exam, your doctor will carefully examine the affected area, looking for any signs or symptoms that may indicate the presence of chondrosarcoma. This examination may involve feeling for lumps or abnormalities, checking for pain or tenderness, and assessing your range of motion. […] Imaging tests play a crucial role in diagnosing chondrosarcoma by providing detailed images of the affected area. […] A biopsy is necessary to confirm a diagnosis of chondrosarcoma. It involves removing a small sample of tissue from a suspected tumour site.

• #19 Chondrosarcoma | Children’s Hospital of Philadelphia

  https://www.chop.edu/conditions-diseases/chondrosarcoma

  Chondrosarcoma occurs when abnormal cartilage cells divide and grow. […] Diagnosing a chondrosarcoma begins with a complete medical history and physical examination of your child. A detailed neurological assessment may also be performed. This involves a series of questions and tests to check the brain, spinal cord and nerve function. […] At Children’s Hospital of Philadelphia (CHOP), clinical experts may use a variety of diagnostic tests to diagnose chondrosarcoma, including: X-rays, which produce images of bones. Magnetic resonance imaging (MRI), which uses a combination of large magnets, radiofrequencies and a computer to produce detailed images of organs, soft tissues, muscles, ligaments and other structures within the body. Your child is exposed to no radiation during an MRI. Computed tomography (CT) scan, which uses a combination of X-rays and computer technology to examine bones and produces cross-sectional images („slices”) of the body. Needle biopsy, which is a procedure where a doctor places a small needle through the skin and into the lesion to withdraw a small sample of the abnormal tissue. The tissue is analyzed to confirm any findings. Radioisotope bone scan, which can help locate areas of abnormal growth. EOS imaging, an imaging technology that creates 3-dimensional models from two flat images. Unlike a CT scan, EOS images are taken while the child is in an upright or standing position, enabling improved diagnosis due to weight-bearing positioning.

• #20 Chondrosarcoma – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK538132/

  Chondrosarcomas are malignant cartilaginous neoplasms with diverse morphological features and clinical behavior. They account for about 20 percent of all primary malignant tumors of the bone and usually arise in the pelvis or long bones. Primary or conventional chondrosarcoma arises in preexisting normal bone and is distinguished from the rarer secondary tumors, which occur within a preexisting enchondroma or osteochondroma. […] The radiographic features of chondrosarcoma are often very characteristic, and a definitive diagnosis can usually be made by imaging examination alone. […] Tissue biopsy is essential to diagnose chondrosarcoma and differentiate it from other malignant or benign bone tumors. Biopsy should be taken from the most aggressive portion of cancer as determined by imaging. […] Correlation between gross, radiographic, and microscopic features of the lesion is crucial to establish the definitive diagnosis of chondrosarcoma.

• #21 Chondrosarcoma | Sarcoma Oncology Center

  https://sarcomaoncology.com/types-of-sarcoma/bone-sarcomas/chondrosarcoma/

  Chondrosarcoma is a type of bone sarcoma that develops in cartilage cells and accounts for 20% of all primary bone tumors. […] The radiographic features of chondrosarcoma typically exhibit distinct features, making diagnosing this type of bone tumor easy. […] Tests and procedures for the diagnosis of chondrosarcoma may include: […] Imaging tests are conducted to detect unusual changes in bones that can indicate the presence of the tumor. Imaging tests like MRI, CT scan, and PET scan can provide detailed pictures of organs and reveal the nature of the tumor, such as its size and growth rate. […] A biopsy involves extracting a tissue sample from the affected area. It is done to determine the presence and nature of tumor cells.

• #22

  https://www.beaumont.org/treatments/chondrosarcoma-diagnosis

  In addition to a complete medical history and physical examination, diagnostic procedures for chondrosarcoma may include the following: […] biopsy – a procedure in which tissue samples are removed (with a needle or during surgery) from the body for examination under a microscope; to determine if cancer or other abnormal cells are present. […] x-ray – a diagnostic test which uses invisible electromagnetic energy beams to produce images of internal tissues, bones, and organs onto film. […] computed tomography scan (also called a CT or CAT scan) – a diagnostic imaging procedure that uses a combination of x-rays and computer technology to produce cross-sectional images (often called slices), both horizontally and vertically, of the body. A CT scan shows detailed images of any part of the body, including the bones, muscles, fat, and organs. CT scans are more detailed than general x-rays. […] magnetic resonance imaging (MRI) – a diagnostic procedure that uses a combination of large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures within the body.

• #23 Chondrosarcoma

  https://www.massgeneral.org/orthopaedics/oncology/conditions-and-treatments/chondrosarcoma

  Chondrosarcoma is a malignant cartilage producing tumor of bone, the second most common after osteosarcoma. […] Determining Diagnosis: Bone biopsy with conscious sedation done by our musculoskeletal radiologist. Initial staging scans (e.g. bone scan, chest CT, MRI) to determine if the disease is localized or has spread (metastasized). Our sarcoma pathologists confirm diagnosis, which may take up to 1-2 weeks due to the specialized testing of tissue. Malignant bone tumors are graded 1 (low), 2 (intermediate), 3 (high), depending on how aggressive the tumor is. […] Imaging: X-rays show a lesion with defined borders that may contain popcorn, spotty or ring-and-arc calcifications, which are characteristics of cartilage tumors. High-grade tumors usually have areas of cortical destruction (fractures) with a large soft tissue mass. Additional imaging with MRI or CT helps identify extent of the tumor. A bone scan shows significant uptake of the contrast dye.

• #24 Chondrosarcoma

  https://www.massgeneral.org/orthopaedics/oncology/conditions-and-treatments/chondrosarcoma

  Chondrosarcoma is a malignant cartilage producing tumor of bone, the second most common after osteosarcoma. […] Determining Diagnosis: Bone biopsy with conscious sedation done by our musculoskeletal radiologist. Initial staging scans (e.g. bone scan, chest CT, MRI) to determine if the disease is localized or has spread (metastasized). Our sarcoma pathologists confirm diagnosis, which may take up to 1-2 weeks due to the specialized testing of tissue. Malignant bone tumors are graded 1 (low), 2 (intermediate), 3 (high), depending on how aggressive the tumor is. […] Imaging: X-rays show a lesion with defined borders that may contain popcorn, spotty or ring-and-arc calcifications, which are characteristics of cartilage tumors. High-grade tumors usually have areas of cortical destruction (fractures) with a large soft tissue mass. Additional imaging with MRI or CT helps identify extent of the tumor. A bone scan shows significant uptake of the contrast dye.

• #25 Chondrosarcoma

  https://www.massgeneral.org/orthopaedics/oncology/conditions-and-treatments/chondrosarcoma

  Chondrosarcoma is a malignant cartilage producing tumor of bone, the second most common after osteosarcoma. […] Determining Diagnosis: Bone biopsy with conscious sedation done by our musculoskeletal radiologist. Initial staging scans (e.g. bone scan, chest CT, MRI) to determine if the disease is localized or has spread (metastasized). Our sarcoma pathologists confirm diagnosis, which may take up to 1-2 weeks due to the specialized testing of tissue. Malignant bone tumors are graded 1 (low), 2 (intermediate), 3 (high), depending on how aggressive the tumor is. […] Imaging: X-rays show a lesion with defined borders that may contain popcorn, spotty or ring-and-arc calcifications, which are characteristics of cartilage tumors. High-grade tumors usually have areas of cortical destruction (fractures) with a large soft tissue mass. Additional imaging with MRI or CT helps identify extent of the tumor. A bone scan shows significant uptake of the contrast dye.

• #26 Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients | PLOS One

  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173665

  Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor survival. There are many confusing issues concerning the imaging feature that can facilitate early diagnosis and the factors that might be related to outcomes. […] Identifying these imaging features is not only essential to raise suspicious of this lesion, but also to help guide choice of preoperative biopsy site or multifocal sampling at initial diagnosis. […] Radiographs demonstrating aggressive osseous destruction or cortical infiltration, large unmineralized soft tissue mass, pathological fracture, area with osteoid matrix and rapid progression were suggestive of dedifferentiation. […] The presence of dedifferentiated component raised the possibility of neo-adjuvant or adjuvant chemotherapy and radiation.

• #27

  https://www.beaumont.org/treatments/chondrosarcoma-diagnosis

  In addition to a complete medical history and physical examination, diagnostic procedures for chondrosarcoma may include the following: […] biopsy – a procedure in which tissue samples are removed (with a needle or during surgery) from the body for examination under a microscope; to determine if cancer or other abnormal cells are present. […] x-ray – a diagnostic test which uses invisible electromagnetic energy beams to produce images of internal tissues, bones, and organs onto film. […] computed tomography scan (also called a CT or CAT scan) – a diagnostic imaging procedure that uses a combination of x-rays and computer technology to produce cross-sectional images (often called slices), both horizontally and vertically, of the body. A CT scan shows detailed images of any part of the body, including the bones, muscles, fat, and organs. CT scans are more detailed than general x-rays. […] magnetic resonance imaging (MRI) – a diagnostic procedure that uses a combination of large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures within the body.

• #28 Chondrosarcoma – OrthoPaedia

  https://www.orthopaedia.com/chondrosarcoma/

  Chondrosarcoma is a malignant tumor of bone that forms cartilage. Chondrosarcomas are classified histologically as low grade, intermediate grade, or high-grade. Clinical aggressiveness is highly correlated to the histologic grade of the tumor, but lesion size, bone of origin and location within the bone can affect prognosis as well. […] The radiographic hallmark of chondrosarcoma is a mass with calcified cartilage and destruction of the nearby bone. […] Magnetic resonance imaging (MRI) and computerized tomography (CT) are often employed as well. CT is especially adept at detecting matrix mineralization and cortical changes. MRI can assess marrow involvement and soft tissue masses. […] Intermediate- and high-grade chondrosarcomas are usually recognized histologically with ease. Distinguishing low-grade malignancies from benign lesions, however, is more challenging. Moreover, cartilage lesions are defined not only by histology but also their radiographic and clinical findings.

• #29 Chondrosarcoma: A Clinical Review

  https://www.mdpi.com/2077-0383/12/7/2506

  Current guidelines recommend plain radiographs and cross sectional imaging of the entire involved bone to evaluate the lesion and assess for skip metastases. Magnetic resonance imaging demonstrates the extent of tumor invasion into the surrounding tissues, relationship to critical structures and presence of skip lesions. In the setting of contradictions to MRI, computed tomography (CT) can be utilized. A CT scan of the chest should be performed in all patients to detect the presence of pulmonary metastases. […] The diagnosis and grading of chondrosarcoma remain challenging, in particular on a biopsy specimen, and treatment decisions should be made by a multidisciplinary team.

• #30

  https://www.americanoncology.com/cancer-we-treat/diagnosis/chondrosarcoma

  Chest X-ray: Several patients develop lung metastasis of chondrosarcomas. […] PET scan: In the PET scan, the radioactive sugar derivative is injected into the vessels. […] EOS imaging: EOS imaging involves using ultra-low-dose radiations to obtain high-quality images. […] Biopsy: If the imaging tests provide convincing evidence about the presence of chondrosarcoma or other bone-related tumors, the patients are advised for a biopsy.

• #31 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  Detecting chondrosarcoma of the brain and spine is difficult and requires a multidisciplinary approach, including a team of specialists comprising a neurologist, neurosurgeon, oncologist, radiologist, and a pathologist. This group of specialists will work together to review test results, confirm your diagnosis, and develop a treatment plan. […] Early detection of chondrosarcoma of the brain and spine is crucial for a positive outcome, as the cancer can be slow-growing and early treatment can be more effective. […] If any symptoms you report indicate a possible chondrosarcoma, additional tests may be ordered. Some of the diagnostic methods for detection include: MRI is the most sensitive and specific imaging modality for detecting chondrosarcoma of the brain and spine; it can show the tumor’s size, shape, and relationship to surrounding structures. A biopsy is the only way to confirm the diagnosis of chondrosarcoma. A small sample of the tumor is removed and examined under a microscope to confirm the diagnosis.

• #32

  https://www.beaumont.org/treatments/chondrosarcoma-diagnosis

  In addition to a complete medical history and physical examination, diagnostic procedures for chondrosarcoma may include the following: […] biopsy – a procedure in which tissue samples are removed (with a needle or during surgery) from the body for examination under a microscope; to determine if cancer or other abnormal cells are present. […] x-ray – a diagnostic test which uses invisible electromagnetic energy beams to produce images of internal tissues, bones, and organs onto film. […] computed tomography scan (also called a CT or CAT scan) – a diagnostic imaging procedure that uses a combination of x-rays and computer technology to produce cross-sectional images (often called slices), both horizontally and vertically, of the body. A CT scan shows detailed images of any part of the body, including the bones, muscles, fat, and organs. CT scans are more detailed than general x-rays. […] magnetic resonance imaging (MRI) – a diagnostic procedure that uses a combination of large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures within the body.

• #33 Chondrosarcoma – OrthoPaedia

  https://www.orthopaedia.com/chondrosarcoma/

  Chondrosarcoma is a malignant tumor of bone that forms cartilage. Chondrosarcomas are classified histologically as low grade, intermediate grade, or high-grade. Clinical aggressiveness is highly correlated to the histologic grade of the tumor, but lesion size, bone of origin and location within the bone can affect prognosis as well. […] The radiographic hallmark of chondrosarcoma is a mass with calcified cartilage and destruction of the nearby bone. […] Magnetic resonance imaging (MRI) and computerized tomography (CT) are often employed as well. CT is especially adept at detecting matrix mineralization and cortical changes. MRI can assess marrow involvement and soft tissue masses. […] Intermediate- and high-grade chondrosarcomas are usually recognized histologically with ease. Distinguishing low-grade malignancies from benign lesions, however, is more challenging. Moreover, cartilage lesions are defined not only by histology but also their radiographic and clinical findings.

• #34 Chondrosarcoma: A Clinical Review

  https://www.mdpi.com/2077-0383/12/7/2506

  Current guidelines recommend plain radiographs and cross sectional imaging of the entire involved bone to evaluate the lesion and assess for skip metastases. Magnetic resonance imaging demonstrates the extent of tumor invasion into the surrounding tissues, relationship to critical structures and presence of skip lesions. In the setting of contradictions to MRI, computed tomography (CT) can be utilized. A CT scan of the chest should be performed in all patients to detect the presence of pulmonary metastases. […] The diagnosis and grading of chondrosarcoma remain challenging, in particular on a biopsy specimen, and treatment decisions should be made by a multidisciplinary team.

• #35 Chondrosarcoma | Brain Tumor Center | Stanford Medicine

  https://med.stanford.edu/brain-tumor/conditions/chondrosarcoma.html

  Chordomas and chondrosarcomas are typically heterogeneously bright on T2-weighted MRI images, which can aid with diagnosis. […] While MRI is superior to CT in delineating the extent of the lesion because it offers anatomic detail and tissue contrast, CT scan is effective for evaluating cortical bone and calcification. […] Biopsy and histologic studies are necessary to confirm the diagnosis, and distinguish chordomas from chondrosarcomas.

• #36 The Radiology Assistant : Cartilage tumors

  https://radiologyassistant.nl/musculoskeletal/bone-tumors/chondrotumors-1

  Since 2020 intermediate lesions in the appendicular skeleton are called ACT, while the same lesions located in the axial skeleton are called chondrosarcoma grade I (CS-I) because they have a poorer outcome. […] Given these developments, the most important task for the musculoskeletal radiologist is to differentiate ACTs from high grade chondrosarcomas. […] On fluid sensitive sequences – preferably T2W with fat suppression – cartilage nodules are hyperintense and grouped together. After gadolinium contrast administration, cartilage tumors enhance with a typical septonodular enhancement. This feature is helpful in distinguishing cartilage tumors from other bone tumors. […] Unfortunately, diffusion weighted imaging has been shown not to be of use in differentiating low grade from high grade cartilage tumors.

• #37

  https://www.americanoncology.com/cancer-we-treat/diagnosis/chondrosarcoma

  Diagnosis of chondrosarcoma is made through the following methods: […] Medical history and physical examination: The symptoms of the patient are required to be thoroughly evaluated to rule out the presence of any other disease of the bones. […] Blood tests: Blood tests provide useful information about the overall health of the body. […] Preliminary radiography: Preliminary radiography is the initial imaging tests performed to determine the overall health of the affected tissues. […] Magnetic resonance imaging: MRI provides important information about the anatomical variations of the affected site. […] Computed tomography: Computed tomography takes images of the affected bone in different slices through X-rays. […] Bone scan: A bone scan is performed to detect abnormalities in the bone.

• #38 Chondrosarcoma: Symptoms, Causes, Diagnosis, Treatment

  https://www.webmd.com/cancer/what-is-chondrosarcoma

  What Tests Will I Need? […] It can be hard to tell a benign tumor from a slow-growing chondrosarcoma, and the symptoms can sometimes look like some other bone problem, such as an infection. Your doctor will ask you to get some tests to figure out what’s going on. […] Physical exam. Your doctor will check your body and ask questions about your health history, including your symptoms and any illnesses that run in your family. […] Imaging tests. You may get some of these: Bone scans show damage and where the cancer has spread. You take a substance with a low amount of radioactivity that gets soaked up by cancer cells. Those areas, called hot spots, look dark gray or black on the image. […] CT scans are powerful X-rays that make detailed pictures inside your body. They help your doctor find the cancer and see if it moved into other areas.

• #39 Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials

  https://www.mdpi.com/2072-6694/15/18/4581

  Imaging plays an important role in the accurate treatment and diagnosis of MCS. Based solely on imaging diagnostics, there is a high probability that MCS is recognized as a different tumor, as CT scans are non-specific. The main imaging methods in the diagnosis of MCS include cases, X-ray, computed tomography (CT), and magnetic resonance imaging (MRI), as well as positron emission tomography (PET). Imaging should be followed by biopsy. In CT, chondroid mineralization is usually seen, and the lesion may appear heavily calcified. However, ‘finely stippled’ calcification may be more common. On MRI, compared to other conventional chondrosarcomas, MCS has a different pattern of contrast enhancement. The diffuse and typical chondroid septal and peripheral enhancement is often absent. A feature not shown in other chondrosarcomas but presented in MCS, is low-signal, serpentine, and high-flow vessels in some areas. In conclusion, the picture suggestive of the diagnosis of MCS is an aggressive osseous lesion with subtle chondroid matrix mineralization and an intermediate signal on T2WI, which is lower than in conventional chondrosarcoma.

• #40 Chondrosarcoma – Symptoms, Types, Causes & Diagnosis

  https://www.ganeshdiagnostic.com/blog/chondrosarcoma-cancer-symptoms-types-causes-and-diagnosis

  When cells mutate and multiply uncontrollably, develop cancer. A bone cancer called chondrosarcoma begins in cartilage cells. The second most frequent primary bone cancer in adults is chondrosarcoma. The pelvis, scapula, sternum, and ribs are the axial skeleton bones that are most frequently affected by chondrosarcoma. Chondrosarcoma must be diagnosed and distinguished from other malignant and benign bone tumors via tissue biopsy. Imaging should be used to pinpoint the most aggressive area of the malignancy for biopsy. The major treatment for chondrosarcoma is surgery. Chondrosarcoma grading is important and helpful in predicting histological behavior. The prognosis is based on how quickly the cancer is identified and treated. […] If you have been diagnosed with chondrosarcoma or exhibit any of its symptoms, you must contact a doctor. The prognosis can be improved and complications can be avoided with early detection and treatment.

• #41 Chondrosarcoma – NCI

  https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/chondrosarcoma

  How is CS diagnosed? […] Imaging: If you have symptoms of CS, your doctor will use imaging scans such as CT and MRI to look at where the tumor is and how big it is. They will also check for signs that the tumor has spread to other parts of the body. […] Biopsy: To check if the tumor is CS, your doctor will do a biopsy, taking a small sample from the tumor with a needle. An expert, called a pathologist, will study cells from the sample under the microscope to see what kind of tumor it is. […] Getting the correct diagnosis is very important to get the right treatment.

• #42

  https://www.beaumont.org/treatments/chondrosarcoma-diagnosis

  In addition to a complete medical history and physical examination, diagnostic procedures for chondrosarcoma may include the following: […] biopsy – a procedure in which tissue samples are removed (with a needle or during surgery) from the body for examination under a microscope; to determine if cancer or other abnormal cells are present. […] x-ray – a diagnostic test which uses invisible electromagnetic energy beams to produce images of internal tissues, bones, and organs onto film. […] computed tomography scan (also called a CT or CAT scan) – a diagnostic imaging procedure that uses a combination of x-rays and computer technology to produce cross-sectional images (often called slices), both horizontally and vertically, of the body. A CT scan shows detailed images of any part of the body, including the bones, muscles, fat, and organs. CT scans are more detailed than general x-rays. […] magnetic resonance imaging (MRI) – a diagnostic procedure that uses a combination of large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures within the body.

• #43 Chondrosarcoma | Types | Causes | Symptoms | Diagnosis | Treatment

  https://www.icliniq.com/articles/cancer/chondrosarcoma

  Chondrosarcoma is a type of cancer that affects the hard and soft tissues. The cancer is known to occur in pelvic bones, shoulder, and hip commonly. […] Diagnosis requires precise tools, and the treatment is usually a long-term process. […] The doctor will test the patient in a clinical setting, noting the patient’s health condition and medical history. The following tests would be required to support the clinical examination. […] Positron emission tomography uses highly radioactive substances for imaging. It is known to be helpful for identifying the condition of chondrosarcoma. […] An X-ray is a reliable tool when it comes to bone-related disorders. […] MRI Scan (Magnetic Resonance Imaging Scan): It helps in the identification of the involvement of the tumor. […] Biopsy can be obtained by either an open technique or a closed technique.

• #44 Chondrosarcoma | Bone Cancer Research Trust

  https://www.bcrt.org.uk/information/information-by-type/chondrosarcoma/

  Once an abnormality is found in a bone that suggests the possibility of cancer, the patient will be referred to a bone sarcoma surgical centre. […] When a person is referred to a bone sarcoma surgical centre, further tests will be done to find out more and to confirm whether the patient has bone cancer, and if so what type. […] A bone biopsy is a specialised procedure that can be performed by a specialist in orthopaedic surgery or sarcoma radiology at a bone cancer surgical centre. A biopsy involves taking a small sample of a lump or tumour so that a pathologist can examine the cells in the sample and determine whether the lump is cancerous or not. […] The main and still the most successful treatment option for chondrosarcoma is surgery to remove the tumour (surgical resection). […] For higher-grade tumours, such as dedifferentiated or mesenchymal chondrosarcomas, which are at higher risk of recurrence and spread (metastasis); adjuvant therapies such as radiotherapy, chemotherapy or proton therapy may be used. […] The Bone Cancer Research Trust is actively involved in funding research, especially translational research to help to find new treatments. Translational research is research that bridges the gap between promising findings in the laboratory from basic research and their clinical use in patients.

• #45 Chondrosarcoma – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK538132/

  Chondrosarcomas are malignant cartilaginous neoplasms with diverse morphological features and clinical behavior. They account for about 20 percent of all primary malignant tumors of the bone and usually arise in the pelvis or long bones. Primary or conventional chondrosarcoma arises in preexisting normal bone and is distinguished from the rarer secondary tumors, which occur within a preexisting enchondroma or osteochondroma. […] The radiographic features of chondrosarcoma are often very characteristic, and a definitive diagnosis can usually be made by imaging examination alone. […] Tissue biopsy is essential to diagnose chondrosarcoma and differentiate it from other malignant or benign bone tumors. Biopsy should be taken from the most aggressive portion of cancer as determined by imaging. […] Correlation between gross, radiographic, and microscopic features of the lesion is crucial to establish the definitive diagnosis of chondrosarcoma.

• #46 Chondrosarcoma: Challenges in diagnosis, grading and the importance of proper classification – CS Foundation | CS Foundation

  https://csfshayna.org/site/chondrosarcoma-challenges-in-diagnosis-grading-and-the-importance-of-proper-classification/

  Chondrosarcomas are malignant mesenchymal neoplasms of bone which produce cartilage matrix. […] Therefore, the role of the pathologist is critical in properly grading and the classification of chondrosarcomas as histologic grade and subtype greatly dictates treatment and predicts behavior and prognosis. […] The grade of chondrosarcoma is an important predictor of behavior and subsequent clinical outcome; however, important caveats need mentioning. First, definitive grading is not always possible on biopsy specimens. Second, histologic grading of chondrosarcoma is subjective as diagnostic criteria are not well established. Third, many chondrosarcomas may progress (transition to a higher but not a lower grade) and, therefore, adequate sampling of a resection specimen by the pathologist is necessary to evaluate for higher grade areas.

• #47 Dedifferentiated chondrosarcoma of the ring finger: a case report of an exceptional surgical treatment and review of literature | Published in Orthopedic Reviews

  https://orthopedicreviews.openmedicalpublishing.org/article/33581-dedifferentiated-chondrosarcoma-of-the-ring-finger-a-case-report-of-an-exceptional-surgical-treatment-and-review-of-literature

  The DDCS is a rare, highly malignant tumor characterized by two distinct histopathologic components. The diagnosis is insidious, and the prognosis is poor. […] Since patients with DDCS has a poorer prognosis than patients affected by CS, it is fundamental to make an accurate diagnosis and consequently to offer an adequate surgical treatment, improving, as far as possible, the survival of these patients. […] The DDCS diagnosis could be difficult, mostly in small bones of the hand and feet. Despite this, it is fundamental to make a differential diagnosis between benign chondroid lesion, CS, and DDCS. The treatment, but above all the prognosis, will be different among these three. […] The histologic diagnosis of DDCS could be challenging, especially with limited small biopsy specimens. If the dedifferentiated component is poorly represented, the pathologist will see only the differentiated one. Therefore, it is significant to withdraw the biopsy fragment as representative of the entire lesion possible.

• #48 Dedifferentiated chondrosarcoma of the ring finger: a case report of an exceptional surgical treatment and review of literature | Published in Orthopedic Reviews

  https://orthopedicreviews.openmedicalpublishing.org/article/33581-dedifferentiated-chondrosarcoma-of-the-ring-finger-a-case-report-of-an-exceptional-surgical-treatment-and-review-of-literature

  The DDCS is a rare, highly malignant tumor characterized by two distinct histopathologic components. The diagnosis is insidious, and the prognosis is poor. […] Since patients with DDCS has a poorer prognosis than patients affected by CS, it is fundamental to make an accurate diagnosis and consequently to offer an adequate surgical treatment, improving, as far as possible, the survival of these patients. […] The DDCS diagnosis could be difficult, mostly in small bones of the hand and feet. Despite this, it is fundamental to make a differential diagnosis between benign chondroid lesion, CS, and DDCS. The treatment, but above all the prognosis, will be different among these three. […] The histologic diagnosis of DDCS could be challenging, especially with limited small biopsy specimens. If the dedifferentiated component is poorly represented, the pathologist will see only the differentiated one. Therefore, it is significant to withdraw the biopsy fragment as representative of the entire lesion possible.

• #49 Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients | PLOS One

  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173665

  Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor survival. There are many confusing issues concerning the imaging feature that can facilitate early diagnosis and the factors that might be related to outcomes. […] Identifying these imaging features is not only essential to raise suspicious of this lesion, but also to help guide choice of preoperative biopsy site or multifocal sampling at initial diagnosis. […] Radiographs demonstrating aggressive osseous destruction or cortical infiltration, large unmineralized soft tissue mass, pathological fracture, area with osteoid matrix and rapid progression were suggestive of dedifferentiation. […] The presence of dedifferentiated component raised the possibility of neo-adjuvant or adjuvant chemotherapy and radiation.

• #50 Chondrosarcoma: Challenges in diagnosis, grading and the importance of proper classification – CS Foundation | CS Foundation

  https://csfshayna.org/site/chondrosarcoma-challenges-in-diagnosis-grading-and-the-importance-of-proper-classification/

  Chondrosarcomas are malignant mesenchymal neoplasms of bone which produce cartilage matrix. […] Therefore, the role of the pathologist is critical in properly grading and the classification of chondrosarcomas as histologic grade and subtype greatly dictates treatment and predicts behavior and prognosis. […] The grade of chondrosarcoma is an important predictor of behavior and subsequent clinical outcome; however, important caveats need mentioning. First, definitive grading is not always possible on biopsy specimens. Second, histologic grading of chondrosarcoma is subjective as diagnostic criteria are not well established. Third, many chondrosarcomas may progress (transition to a higher but not a lower grade) and, therefore, adequate sampling of a resection specimen by the pathologist is necessary to evaluate for higher grade areas.

• #51 Chondrosarcoma: Symptoms, Causes & Treatment

  https://my.clevelandclinic.org/health/diseases/22112-chondrosarcoma

  Chondrosarcomas are a group of rare bone cancer tumors that begin in your cartilage. […] The most common treatment is surgery to remove cancerous cartilage and bone. […] Overall, 79% of people with chondrosarcoma are alive five years after diagnosis. […] A healthcare provider will ask questions about your symptoms, including: When you first noticed them. […] Theyll do a physical examination and may order imaging tests or a biopsy. […] To diagnose chondrosarcomas, healthcare providers may order the following imaging tests: X-ray. […] Your provider may refer you to an orthopaedist, a surgeon who diagnoses and treats conditions including bone cancer, to do a biopsy. […] A pathologist will examine the tissue sample for signs of cancerous cells. If cells are cancerous, theyll identify the tumor type and establish a tumor grade.

• #52 Chondrosarcoma: A Clinical Review

  https://www.mdpi.com/2077-0383/12/7/2506

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability. Additionally, there is a high rate of biopsy sampling error, particular in pelvic-based lesions. The preoperative histologic grade should be taken into consideration alongside radiologic and clinical assessment in determining optimal management.

• #53 Chondrosarcoma: A Clinical Review

  https://www.mdpi.com/2077-0383/12/7/2506

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability. Additionally, there is a high rate of biopsy sampling error, particular in pelvic-based lesions. The preoperative histologic grade should be taken into consideration alongside radiologic and clinical assessment in determining optimal management.

• #54 Chondrosarcoma | Cedars-Sinai

  https://www.cedars-sinai.org/health-library/diseases-and-conditions/c/chondrosarcoma-1.html

  Chondrosarcoma is a type of bone cancer that starts in cartilage cells. […] Chondrosarcoma is the second most common type of primary bone cancer in adults. […] Symptoms can include a large mass on the affected bone, and pain that gets worse over time. […] How is chondrosarcoma diagnosed? […] The healthcare provider will ask about your health history and symptoms. A physical exam will be done. You may also need tests, such as: […] After a diagnosis of chondrosarcoma, you’ll need more tests. These help your healthcare providers learn more about your overall health and the cancer. […] Your healthcare provider will talk with you about what your cancer stage and grade mean for your treatment. […] Treatment may include surgery, radiation therapy, or chemotherapy.

• #55 Chondrosarcoma – Macmillan Cancer Support | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/bone-cancer/chondrosarcoma

  The results of your tests give your cancer doctor information about the stage and grade of the cancer. […] The stage of the cancer refers to its size and whether it has spread outside the bone. […] The grade of the cancer is how the cancer cells look under the microscope. […] Chondrosarcomas are usually low-grade tumours. […] Surgery is the main treatment for chondrosarcoma. […] Your test results are discussed by a team of specialist health care professionals. […] If your tests show a diagnosis of bone cancer, a team of specialist doctors and other professionals called a multidisciplinary team (MDT) will meet. […] After the MDT meeting, your cancer doctor or specialist nurse will explain the treatment options and possible side effects to you. […] The type of treatment you have depends on: the position of the cancer, the size of the cancer, if it has spread (its stage), the grade of the cancer, the subtype of chondrosarcoma, your general health. […] You may be offered some treatments as part of a clinical trial. […] After you finish treatment, you will have regular check-ups for a few years. […] If you have any problems, or notice any new symptoms in between your regular follow-up appointments, tell your cancer doctor as soon as possible.

• #56 Chondrosarcoma: A Clinical Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10095313/

  Current guidelines recommend plain radiographs and cross sectional imaging of the entire involved bone to evaluate the lesion and assess for skip metastases. […] Magnetic resonance imaging demonstrates the extent of tumor invasion into the surrounding tissues, relationship to critical structures and presence of skip lesions. […] There is no chondrosarcoma-specific staging system; therefore, chondrosarcomas are generally staged using either the Enneking classification or the American Joint Committee on Cancer (AJCC) Staging systems for bone sarcomas. […] The diagnosis and grading of chondrosarcoma remain challenging, in particular on a biopsy specimen, and treatment decisions should be made by a multidisciplinary team.

• #57 Chondrosarcoma – UpToDate

  https://www.uptodate.com/contents/chondrosarcoma

  Chondrosarcomas are a heterogeneous group of malignant bone tumors that all produce chondroid (cartilaginous) matrix. Chondrosarcomas are the third most common primary malignancy of bone after myeloma and osteosarcoma. They account for 20 to 27 percent of primary malignant osseous neoplasms. […] This clinical presentation, diagnosis, and management of chondrosarcoma is presented here. Chondrosarcomas involving the head and neck and skull base, as well as diagnosis and biopsy techniques for general bone tumors, are discussed separately. […] Histologic grade is one of the most important indicators of clinical behavior and prognosis. Conventional chondrosarcomas are graded on a scale from 1 to 3, based upon nuclear size, staining pattern (hyperchromasia), mitotic activity, and degree of cellularity.

• #58 Chondrosarcoma – UpToDate

  https://www.uptodate.com/contents/chondrosarcoma/print

  Chondrosarcomas are a heterogeneous group of malignant bone tumors that all produce chondroid (cartilaginous) matrix. Chondrosarcomas are the third most common primary malignancy of bone after myeloma and osteosarcoma. They account for 20 to 27 percent of primary malignant osseous neoplasms. […] This clinical presentation, diagnosis, and management of chondrosarcoma is presented here. […] Histologic grade is one of the most important indicators of clinical behavior and prognosis. Conventional chondrosarcomas are graded on a scale from 1 to 3, based upon nuclear size, staining pattern (hyperchromasia), mitotic activity, and degree of cellularity. […] The term „atypical cartilaginous tumor” (ACT) was introduced in the World Health Organization (WHO) 2013 classification system to define more accurately the clinical behavior of well-differentiated/low-grade lesions, previously termed „chondrosarcoma grade 1” (CS1) that, especially in the long bones, behave in a locally aggressive manner and do not metastasize.

• #59 Chondrosarcoma – UpToDate

  https://www.uptodate.com/contents/chondrosarcoma

  The term „atypical cartilaginous tumor” (ACT) was introduced in the World Health Organization (WHO) 2013 classification system to define more accurately the clinical behavior of well-differentiated/low-grade lesions, previously termed „chondrosarcoma grade 1” (CS1) that, especially in the long bones, behave in a locally aggressive manner and do not metastasize.

• #60 Chondrosarcoma – UpToDate

  https://www.uptodate.com/contents/chondrosarcoma/print

  Chondrosarcomas are a heterogeneous group of malignant bone tumors that all produce chondroid (cartilaginous) matrix. Chondrosarcomas are the third most common primary malignancy of bone after myeloma and osteosarcoma. They account for 20 to 27 percent of primary malignant osseous neoplasms. […] This clinical presentation, diagnosis, and management of chondrosarcoma is presented here. […] Histologic grade is one of the most important indicators of clinical behavior and prognosis. Conventional chondrosarcomas are graded on a scale from 1 to 3, based upon nuclear size, staining pattern (hyperchromasia), mitotic activity, and degree of cellularity. […] The term „atypical cartilaginous tumor” (ACT) was introduced in the World Health Organization (WHO) 2013 classification system to define more accurately the clinical behavior of well-differentiated/low-grade lesions, previously termed „chondrosarcoma grade 1” (CS1) that, especially in the long bones, behave in a locally aggressive manner and do not metastasize.

• #61 The Radiology Assistant : Cartilage tumors

  https://radiologyassistant.nl/musculoskeletal/bone-tumors/chondrotumors-1

  Since 2020 intermediate lesions in the appendicular skeleton are called ACT, while the same lesions located in the axial skeleton are called chondrosarcoma grade I (CS-I) because they have a poorer outcome. […] Given these developments, the most important task for the musculoskeletal radiologist is to differentiate ACTs from high grade chondrosarcomas. […] On fluid sensitive sequences – preferably T2W with fat suppression – cartilage nodules are hyperintense and grouped together. After gadolinium contrast administration, cartilage tumors enhance with a typical septonodular enhancement. This feature is helpful in distinguishing cartilage tumors from other bone tumors. […] Unfortunately, diffusion weighted imaging has been shown not to be of use in differentiating low grade from high grade cartilage tumors.

• #62

  https://www.orthobullets.com/pathology/8023/chondrosarcoma

  Chondrosarcoma is the second most common malignant primary bone tumor. These cancers are composed of malignant chondrocytes. There are various subtypes of chondrosarcoma, each with unique characteristics. „Conventional” chondrosarcoma accounts for 90% of chondrosarcomas and typically presents in adults over 40 with progressive pain. […] Diagnosis is made by correlating clinical and imaging (x-ray, CT, MRI) findings with lesional biopsy showing malignant cartilage that permeates and entraps pre-existing bone trabeculae. […] Treatment is usually wide surgical resection; conventional chondrosarcomas do not respond to chemotherapy or radiation.

• #63 Chondrosarcoma: A Clinical Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10095313/

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability.

• #64 Chondrosarcoma: A Clinical Review

  https://www.mdpi.com/2077-0383/12/7/2506

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability. Additionally, there is a high rate of biopsy sampling error, particular in pelvic-based lesions. The preoperative histologic grade should be taken into consideration alongside radiologic and clinical assessment in determining optimal management.

• #65 Chondrosarcoma: A Clinical Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10095313/

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability.

• #66 Chondrosarcoma: A Clinical Review

  https://www.mdpi.com/2077-0383/12/7/2506

  Chondrosarcomas present a diagnostic dilemma, particularly in the differentiation between high- and intermediate-grade tumors and that of low-grade tumors from benign enchondromas. […] Prompt diagnosis and treatment has the potential to reduce the disease burden and may help reduce the risk of metastatic spread and thus improve survival. At present, there are no novel detection methods that have been proven to improve early diagnosis. However, circulating tumor DNA has emerged as a potential promising biomarker to aid in both the diagnosis and residual disease detection in a range of tumors. In chondrosarcoma, isocitrate dehydrogenase (IDH) mutations are commonly found, and early studies suggest serum IDH DNA can be detected in patients with chondrosarcoma. […] Biopsy and subsequent histologic grading of lesional tissue is imperative and helps to direct therapeutic decision making. However, histologic grading of cartilaginous tumors is challenging and is subject to high rates of interobserver variability. Additionally, there is a high rate of biopsy sampling error, particular in pelvic-based lesions. The preoperative histologic grade should be taken into consideration alongside radiologic and clinical assessment in determining optimal management.

• #67 Chondrosarcoma of bone: diagnosis and therapy – Clinical Tree

  https://clinicalpub.com/chondrosarcoma-of-bone-diagnosis-and-therapy/

  Close to 1% of all tumors are primary malignant bone tumors. Out of these, the chondrosarcoma is the second most common primary malignant bone tumor in adults with an incidence of 34/100,000 per year. […] Considering the heterogeneity of cartilage tumors the therapy, the clinical course, and the prognosis depend on the correct diagnosis and initial tumor staging. Therefore, all chondrosarcomas, even the low-grade tumors, should be treated in a specialized tumor center only. […] Chondrosarcoma-associated gene alterations or mutations such as isocitrate dehydrogenase 1 (IDH1) or IDH2 mutations can improve diagnostic efforts. […] In the imaging the ddCS is characterized mainly by the low-grade component with a scalopping sign and a homogenous appearance in most parts of the tumor. The high-grade component is commonly associated with an aggressive osteolytic tumor growth with cortical destruction, tumor necrosis, and frequently an extraosseous tumor formation.

• #68 Biomarkers of chondrosarcoma | Journal of Clinical Pathology

  https://jcp.bmj.com/content/71/7/579

  Clinical outcome prediction is major concern to patients with cancer. […] However, accurate predictors in chondrosarcoma have not been developed, even though chondrosarcoma is the second most common primary bone tumour. […] To decide best therapy, accurate diagnostic markers are also necessary in chondrosarcoma. […] Several microRNAs to regulate vascular endothelial growth factor (VEGF)-A and VEGF-C are also reported. […] Alpha-methylacyl-CoA racemase and periostin are proposed as new biomarkers for differential diagnosis of enchondroma and chondrosarcoma. […] This review summarises that chondrosarcoma diagnostic markers are currently reported. […] The differential diagnosis between enchondroma and low-grade chondrosarcoma is more important than chondrosarcoma staging because of clinical management.

• #69 Biomarkers of chondrosarcoma | Journal of Clinical Pathology

  https://jcp.bmj.com/content/71/7/579

  There are only two known biomarkers that can distinguish between enchondroma and chondrosarcoma. […] AMACR is expressed in most enchondromas, but only in a minority of chondrosarcomas. […] Periostin is only expressed in low-grade chondrosarcomas but not in enchondromas and normal cartilages. […] Follow-up studies for validation of AMACR and periostin should be facilitated.

• #70 The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis | Journal of Orthopaedic Surgery and Research | Full Text

  https://josr-online.biomedcentral.com/articles/10.1186/s13018-020-01748-w

  Although chondrosarcoma normally presents with increased pain, these symptoms and signs can be nonspecific and lead to a misdiagnosis of other musculoskeletal disorders such as osteomyelitis and osteoarthritis. […] 18F-fluorodeoxyglucose (18F-FDG) avidity provides useful information regarding tumor biology and sarcomatous transformation by depicting glucose metabolism and identifying hypermetabolic foci. […] A series of studies have investigated the utility of 18F-FDG PET or PET/CT in the diagnosis and staging of chondrosarcoma and revealed contradictory conclusions. […] The current investigation aimed to further assess the ability of 18F-FDG PET and PET/CT to diagnose chondrosarcoma and to predict the histological grade by performing a meta-analysis. […] The pooled sensitivity and specificity of 18F-FDG PET for diagnosing chondrosarcoma were 0.84 (95% CI, 0.46 to 0.97) and 0.82 (95% CI, 0.55 to 0.94), respectively.

• #71 The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis | Journal of Orthopaedic Surgery and Research | Full Text

  https://josr-online.biomedcentral.com/articles/10.1186/s13018-020-01748-w

  Chondrosarcoma is the second most common primary bone sarcoma; however, unlike other tumors, the biopsy cannot easily make a definite diagnosis or predict the histological grade. This meta-analysis was performed to evaluate the utility of 18F-FDG PET and PET/CT to differentiate chondrosarcoma from benign cartilaginous lesions and to predict the histopathological grade of chondrosarcoma. […] For the diagnosis of chondrosarcoma, the pooled sensitivity, specificity, and DOR of 18F-FDG PET were 0.84 (95% confidence interval [CI] 0.46 to 0.97), 0.82 (95% CI 0.55 to 0.94), and 24.244 (95% CI 1.985 to 96.148), respectively while those of 18F-FDG PET/CT were 0.94 (95% CI 0.86 to 0.97), 0.89 (95% CI 0.82 to 0.93), and 112.999 (95% CI 41.341 to 308.866), respectively. […] In a word, 18F-FDG PET/CT revealed excellent accuracy in the diagnosis of chondrosarcoma and might assist in clinical decision-making.

• #72 The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis | Journal of Orthopaedic Surgery and Research | Full Text

  https://josr-online.biomedcentral.com/articles/10.1186/s13018-020-01748-w

  The pooled sensitivity and specificity of 18F-FDG PET/CT for diagnosing chondrosarcoma were 0.94 (95%CI, 0.86 to 0.97) and 0.89 (95% CI, 0.82 to 0.93), respectively. […] The combined results suggested that SUVmax of benign cartilaginous lesions were slightly lower than that of G1 chondrosarcoma. […] The pooled results revealed that there was no significant difference of SUVmax between G2 and G3 chondrosarcoma. […] The current study was also designed to investigate the potential role of SUVmax to evaluate chondrosarcoma grading. […] SUVmax alone is not sufficient enough for grading chondrosarcoma and no matter what SUV-level of the cartilaginous lesions reveal, biopsy should not be resigned. […] However, SUVmax did present crucial information for the management of chondrosarcoma. […] The relatively high price of 18F-FDG PET and PET/CT restricts its wide application in the clinical setting.

• #73 The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis | Journal of Orthopaedic Surgery and Research | Full Text

  https://josr-online.biomedcentral.com/articles/10.1186/s13018-020-01748-w

  The pooled sensitivity and specificity of 18F-FDG PET/CT for diagnosing chondrosarcoma were 0.94 (95%CI, 0.86 to 0.97) and 0.89 (95% CI, 0.82 to 0.93), respectively. […] The combined results suggested that SUVmax of benign cartilaginous lesions were slightly lower than that of G1 chondrosarcoma. […] The pooled results revealed that there was no significant difference of SUVmax between G2 and G3 chondrosarcoma. […] The current study was also designed to investigate the potential role of SUVmax to evaluate chondrosarcoma grading. […] SUVmax alone is not sufficient enough for grading chondrosarcoma and no matter what SUV-level of the cartilaginous lesions reveal, biopsy should not be resigned. […] However, SUVmax did present crucial information for the management of chondrosarcoma. […] The relatively high price of 18F-FDG PET and PET/CT restricts its wide application in the clinical setting.

• #74 The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis | Journal of Orthopaedic Surgery and Research | Full Text

  https://josr-online.biomedcentral.com/articles/10.1186/s13018-020-01748-w

  Therefore, 18F-FDG PET/CT should be performed only in cases with a high suspicion for malignant cartilaginous tumors prior to each biopsy, as a supplementary tool for assisting diagnosis and grading. […] In a word, 18F-FDG PET/CT revealed excellent accuracy (pooled DOR = 112.999) in the diagnosis of chondrosarcoma and might assist in therapeutic decision-making.

• #75 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  Detecting chondrosarcoma of the brain and spine is difficult and requires a multidisciplinary approach, including a team of specialists comprising a neurologist, neurosurgeon, oncologist, radiologist, and a pathologist. This group of specialists will work together to review test results, confirm your diagnosis, and develop a treatment plan. […] Early detection of chondrosarcoma of the brain and spine is crucial for a positive outcome, as the cancer can be slow-growing and early treatment can be more effective. […] If any symptoms you report indicate a possible chondrosarcoma, additional tests may be ordered. Some of the diagnostic methods for detection include: MRI is the most sensitive and specific imaging modality for detecting chondrosarcoma of the brain and spine; it can show the tumor’s size, shape, and relationship to surrounding structures. A biopsy is the only way to confirm the diagnosis of chondrosarcoma. A small sample of the tumor is removed and examined under a microscope to confirm the diagnosis.

• #76 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  Detecting chondrosarcoma of the brain and spine is difficult and requires a multidisciplinary approach, including a team of specialists comprising a neurologist, neurosurgeon, oncologist, radiologist, and a pathologist. This group of specialists will work together to review test results, confirm your diagnosis, and develop a treatment plan. […] Early detection of chondrosarcoma of the brain and spine is crucial for a positive outcome, as the cancer can be slow-growing and early treatment can be more effective. […] If any symptoms you report indicate a possible chondrosarcoma, additional tests may be ordered. Some of the diagnostic methods for detection include: MRI is the most sensitive and specific imaging modality for detecting chondrosarcoma of the brain and spine; it can show the tumor’s size, shape, and relationship to surrounding structures. A biopsy is the only way to confirm the diagnosis of chondrosarcoma. A small sample of the tumor is removed and examined under a microscope to confirm the diagnosis.

• #77 Chondrosarcoma: Challenges in diagnosis, grading and the importance of proper classification – CS Foundation | CS Foundation

  https://csfshayna.org/site/chondrosarcoma-challenges-in-diagnosis-grading-and-the-importance-of-proper-classification/

  Radiology is an essential component to the proper diagnosis of cartilage neoplasms as most bone pathologists will not render a final diagnosis until they have reviewed the imaging studies with an experienced musculoskeletal radiologist. […] Finally, the treatment of most conventional chondrosarcomas is generally surgery without chemotherapy or radiation; however, the histologic grade, subtype of chondrosarcoma and the clinical stage (tumor size, location, presence or absence of metastasis) are all necessary constituents to the overall multidisciplinary treatment plan.

• #78 Chondrosarcoma – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK538132/

  Chondrosarcomas are malignant cartilaginous neoplasms with diverse morphological features and clinical behavior. They account for about 20 percent of all primary malignant tumors of the bone and usually arise in the pelvis or long bones. Primary or conventional chondrosarcoma arises in preexisting normal bone and is distinguished from the rarer secondary tumors, which occur within a preexisting enchondroma or osteochondroma. […] The radiographic features of chondrosarcoma are often very characteristic, and a definitive diagnosis can usually be made by imaging examination alone. […] Tissue biopsy is essential to diagnose chondrosarcoma and differentiate it from other malignant or benign bone tumors. Biopsy should be taken from the most aggressive portion of cancer as determined by imaging. […] Correlation between gross, radiographic, and microscopic features of the lesion is crucial to establish the definitive diagnosis of chondrosarcoma.

• #79 Chondrosarcoma: Challenges in diagnosis, grading and the importance of proper classification – CS Foundation | CS Foundation

  https://csfshayna.org/site/chondrosarcoma-challenges-in-diagnosis-grading-and-the-importance-of-proper-classification/

  Radiology is an essential component to the proper diagnosis of cartilage neoplasms as most bone pathologists will not render a final diagnosis until they have reviewed the imaging studies with an experienced musculoskeletal radiologist. […] Finally, the treatment of most conventional chondrosarcomas is generally surgery without chemotherapy or radiation; however, the histologic grade, subtype of chondrosarcoma and the clinical stage (tumor size, location, presence or absence of metastasis) are all necessary constituents to the overall multidisciplinary treatment plan.

• #80 How Diagnosis is Critical to Proper Treatment of Chondrosarcoma – CS Foundation | CS Foundation

  https://csfshayna.org/site/how-diagnosis-is-critical-to-proper-treatment-of-chondrosarcoma/

  Chondrosarcoma patients face challenges in diagnosing their rare diseases. This often results in delays and misdiagnoses, with potential serious consequences on treatment decisions, prognosis, and survival. […] The Patient Registry aims to gather valuable information to better understand the patients experience on their diagnostic journey. […] In a previous post on the Chondrosarcoma Registry, we reported that 42.3% of chondrosarcoma patients indicated they were not initially diagnosed with chondrosarcoma (in most cases misdiagnosed). […] Overall, there may be a lot of reasons for the time lapse between initial symptoms and an initial diagnosis. Our results suggest it took approximately 19 months (563 days) before a chondrosarcoma patient received a diagnosis. […] Diagnosing chondrosarcoma is difficult. The gold standard for a proper diagnosis is the tissue biopsy evaluated by a pathologist experienced in diagnosing bone and connective tissue cancers. More research and efforts are needed to accurately diagnose chondrosarcoma at the initial evaluation (the right diagnosis the first time) to avoid delays and misdiagnoses and help prevent serious consequences on treatment prognosis and survival.

• #81 How Diagnosis is Critical to Proper Treatment of Chondrosarcoma – CS Foundation | CS Foundation

  https://csfshayna.org/site/how-diagnosis-is-critical-to-proper-treatment-of-chondrosarcoma/

  Chondrosarcoma patients face challenges in diagnosing their rare diseases. This often results in delays and misdiagnoses, with potential serious consequences on treatment decisions, prognosis, and survival. […] The Patient Registry aims to gather valuable information to better understand the patients experience on their diagnostic journey. […] In a previous post on the Chondrosarcoma Registry, we reported that 42.3% of chondrosarcoma patients indicated they were not initially diagnosed with chondrosarcoma (in most cases misdiagnosed). […] Overall, there may be a lot of reasons for the time lapse between initial symptoms and an initial diagnosis. Our results suggest it took approximately 19 months (563 days) before a chondrosarcoma patient received a diagnosis. […] Diagnosing chondrosarcoma is difficult. The gold standard for a proper diagnosis is the tissue biopsy evaluated by a pathologist experienced in diagnosing bone and connective tissue cancers. More research and efforts are needed to accurately diagnose chondrosarcoma at the initial evaluation (the right diagnosis the first time) to avoid delays and misdiagnoses and help prevent serious consequences on treatment prognosis and survival.

• #82 How Diagnosis is Critical to Proper Treatment of Chondrosarcoma – CS Foundation | CS Foundation

  https://csfshayna.org/site/how-diagnosis-is-critical-to-proper-treatment-of-chondrosarcoma/

  Chondrosarcoma patients face challenges in diagnosing their rare diseases. This often results in delays and misdiagnoses, with potential serious consequences on treatment decisions, prognosis, and survival. […] The Patient Registry aims to gather valuable information to better understand the patients experience on their diagnostic journey. […] In a previous post on the Chondrosarcoma Registry, we reported that 42.3% of chondrosarcoma patients indicated they were not initially diagnosed with chondrosarcoma (in most cases misdiagnosed). […] Overall, there may be a lot of reasons for the time lapse between initial symptoms and an initial diagnosis. Our results suggest it took approximately 19 months (563 days) before a chondrosarcoma patient received a diagnosis. […] Diagnosing chondrosarcoma is difficult. The gold standard for a proper diagnosis is the tissue biopsy evaluated by a pathologist experienced in diagnosing bone and connective tissue cancers. More research and efforts are needed to accurately diagnose chondrosarcoma at the initial evaluation (the right diagnosis the first time) to avoid delays and misdiagnoses and help prevent serious consequences on treatment prognosis and survival.

• #83 How Diagnosis is Critical to Proper Treatment of Chondrosarcoma – CS Foundation | CS Foundation

  https://csfshayna.org/site/how-diagnosis-is-critical-to-proper-treatment-of-chondrosarcoma/

  Chondrosarcoma patients face challenges in diagnosing their rare diseases. This often results in delays and misdiagnoses, with potential serious consequences on treatment decisions, prognosis, and survival. […] The Patient Registry aims to gather valuable information to better understand the patients experience on their diagnostic journey. […] In a previous post on the Chondrosarcoma Registry, we reported that 42.3% of chondrosarcoma patients indicated they were not initially diagnosed with chondrosarcoma (in most cases misdiagnosed). […] Overall, there may be a lot of reasons for the time lapse between initial symptoms and an initial diagnosis. Our results suggest it took approximately 19 months (563 days) before a chondrosarcoma patient received a diagnosis. […] Diagnosing chondrosarcoma is difficult. The gold standard for a proper diagnosis is the tissue biopsy evaluated by a pathologist experienced in diagnosing bone and connective tissue cancers. More research and efforts are needed to accurately diagnose chondrosarcoma at the initial evaluation (the right diagnosis the first time) to avoid delays and misdiagnoses and help prevent serious consequences on treatment prognosis and survival.

• #84 How Diagnosis is Critical to Proper Treatment of Chondrosarcoma – CS Foundation | CS Foundation

  https://csfshayna.org/site/how-diagnosis-is-critical-to-proper-treatment-of-chondrosarcoma/

  Chondrosarcoma patients face challenges in diagnosing their rare diseases. This often results in delays and misdiagnoses, with potential serious consequences on treatment decisions, prognosis, and survival. […] The Patient Registry aims to gather valuable information to better understand the patients experience on their diagnostic journey. […] In a previous post on the Chondrosarcoma Registry, we reported that 42.3% of chondrosarcoma patients indicated they were not initially diagnosed with chondrosarcoma (in most cases misdiagnosed). […] Overall, there may be a lot of reasons for the time lapse between initial symptoms and an initial diagnosis. Our results suggest it took approximately 19 months (563 days) before a chondrosarcoma patient received a diagnosis. […] Diagnosing chondrosarcoma is difficult. The gold standard for a proper diagnosis is the tissue biopsy evaluated by a pathologist experienced in diagnosing bone and connective tissue cancers. More research and efforts are needed to accurately diagnose chondrosarcoma at the initial evaluation (the right diagnosis the first time) to avoid delays and misdiagnoses and help prevent serious consequences on treatment prognosis and survival.

• #85 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  These tests are not always specific for chondrosarcoma of the brain and spine, and a proper diagnosis is made with the combination of imaging and examination of a biopsy. If you have symptoms that may be caused by a brain or spinal tumor, or if you have a family history of bone cancer, it is important to discuss this with your doctor and to have regular checkups. […] Diagnosing chondrosarcomas of the brain and spine involves a complete medical history and physical exam, imaging tests such as X-rays, CT, MRI, and PET scans, biopsy, and sometimes blood tests. Early detection and diagnosis are essential to improve the chances of a successful outcome.

• #86 Chondrosarcoma | Types | Causes | Symptoms | Diagnosis | Treatment

  https://www.icliniq.com/articles/cancer/chondrosarcoma

  In low-grade cases of chondrosarcoma, the prognosis is good. […] Although less aggressive, low-grade chondrosarcoma is a potentially malignant tumor requiring definitive surgery for curative therapy. Early detection and surgical excision results in a favorable long-term prognosis, as it is highly curable. […] The diagnosis of chondrosarcoma can be achieved by, – Physical examination by the doctor. – Imaging tests like MRI (magnetic resonance imaging), X-rays, CT (computed tomography), and bone scan. – Biopsy.

• #87 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  These tests are not always specific for chondrosarcoma of the brain and spine, and a proper diagnosis is made with the combination of imaging and examination of a biopsy. If you have symptoms that may be caused by a brain or spinal tumor, or if you have a family history of bone cancer, it is important to discuss this with your doctor and to have regular checkups. […] Diagnosing chondrosarcomas of the brain and spine involves a complete medical history and physical exam, imaging tests such as X-rays, CT, MRI, and PET scans, biopsy, and sometimes blood tests. Early detection and diagnosis are essential to improve the chances of a successful outcome.

• #88 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  These tests are not always specific for chondrosarcoma of the brain and spine, and a proper diagnosis is made with the combination of imaging and examination of a biopsy. If you have symptoms that may be caused by a brain or spinal tumor, or if you have a family history of bone cancer, it is important to discuss this with your doctor and to have regular checkups. […] Diagnosing chondrosarcomas of the brain and spine involves a complete medical history and physical exam, imaging tests such as X-rays, CT, MRI, and PET scans, biopsy, and sometimes blood tests. Early detection and diagnosis are essential to improve the chances of a successful outcome.

• #89 Chondrosarcoma – New insights in 2023

  https://oncodaily.com/oncolibrary/cancer-types/79627

  Chondrosarcoma is a rare type of cancer that typically begins in the bones but can also occur in the soft tissue near bones. […] Diagnosing chondrosarcoma involves several steps: […] A sample of the tumor tissue is taken and examined under a microscope to confirm the diagnosis and determine the grade of the cancer. […] Early diagnosis and treatment can significantly improve the prognosis and quality of life for individuals with chondrosarcoma.

• #90 Chondrosarcoma Diagnosis | Expert Surgeon | Aaron Cohen-Gadol, MD | Aaron Cohen-Gadol, MD

  https://www.aaroncohen-gadol.com/en/patients/chondrosarcoma/types/diagnosing

  Detecting chondrosarcoma of the brain and spine is difficult and requires a multidisciplinary approach, including a team of specialists comprising a neurologist, neurosurgeon, oncologist, radiologist, and a pathologist. This group of specialists will work together to review test results, confirm your diagnosis, and develop a treatment plan. […] Early detection of chondrosarcoma of the brain and spine is crucial for a positive outcome, as the cancer can be slow-growing and early treatment can be more effective. […] If any symptoms you report indicate a possible chondrosarcoma, additional tests may be ordered. Some of the diagnostic methods for detection include: MRI is the most sensitive and specific imaging modality for detecting chondrosarcoma of the brain and spine; it can show the tumor’s size, shape, and relationship to surrounding structures. A biopsy is the only way to confirm the diagnosis of chondrosarcoma. A small sample of the tumor is removed and examined under a microscope to confirm the diagnosis.

• #91 Chondrosarcoma: Symptoms, Causes, Treatment, and Outlook

  https://www.healthline.com/health/cancer/chondrosarcoma

  Chondrosarcoma is a group of bone cancers that start in the cartilage. […] Catching the cancer before it spreads gives you the best chance of successful treatment. […] How is chondrosarcoma diagnosed? […] If a doctor suspects that you may have a bone cancer, theyll likely order imaging tests to look for a tumor. X-rays are often the first imaging test performed. If something atypical appears on your X-ray, your doctor may order other imaging tests, such as: […] A biopsy is needed to confirm your diagnosis. A biopsy involves the removal of a small section of the tumor for lab analysis. A specialist will examine the tissue under a microscope to confirm your diagnosis. […] Theyll also classify your cancer from grade 1 to 3 based on how quickly its likely to spread based on its cellular features. […] Grade 1 chondrosarcoma is considered the least aggressive, while grade 3 is the most aggressive.

• #92 Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis

  https://www.jcancer.org/v10p2457.htm

  Chondrosarcoma with metastatic disease has a very poor prognosis. However, the prognosis and potential prognostic factors of patients with primary chondrosarcoma of bone and metastasis at presentation have not been documented because of its rarity. Therefore, we examined the prognosis of this special cohort and identify possible prognostic factors. […] The overall survival (OS) and cancer-survival specific (CSS) rates of the entire group at 5 years were 28.4% and 31.2%, respectively. The median OS and CSS were 14.0 2.5 and 17.0 2.6 months, respectively. Multivariate analysis revealed that low tumor grade, surgical treatment, tumor size 10 cm, and first primary tumor were associated with improved OS. Tumor grade, tumor size, and surgery were independent predictors of CSS. […] Among patients with primary chondrosarcoma of bone and metastasis at presentation, low tumor grade, surgical treatment, tumor size 10 cm, and first primary tumor predict prolonged survival.

• #93 Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis

  https://www.jcancer.org/v10p2457.htm

  Chondrosarcoma with metastatic disease has a very poor prognosis. However, the prognosis and potential prognostic factors of patients with primary chondrosarcoma of bone and metastasis at presentation have not been documented because of its rarity. Therefore, we examined the prognosis of this special cohort and identify possible prognostic factors. […] The overall survival (OS) and cancer-survival specific (CSS) rates of the entire group at 5 years were 28.4% and 31.2%, respectively. The median OS and CSS were 14.0 2.5 and 17.0 2.6 months, respectively. Multivariate analysis revealed that low tumor grade, surgical treatment, tumor size 10 cm, and first primary tumor were associated with improved OS. Tumor grade, tumor size, and surgery were independent predictors of CSS. […] Among patients with primary chondrosarcoma of bone and metastasis at presentation, low tumor grade, surgical treatment, tumor size 10 cm, and first primary tumor predict prolonged survival.

• #94 Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis

  https://www.jcancer.org/v10p2457.htm

  Chondrosarcoma with metastatic disease has a very poor prognosis. However, the prognosis and potential prognostic factors of patients with primary chondrosarcoma of bone and metastasis at presentation have not been documented because of its rarity. Therefore, we examined the prognosis of this special cohort and identify possible prognostic factors. […] The overall survival (OS) and cancer-survival specific (CSS) rates of the entire group at 5 years were 28.4% and 31.2%, respectively. The median OS and CSS were 14.0 2.5 and 17.0 2.6 months, respectively. Multivariate analysis revealed that low tumor grade, surgical treatment, tumor size 10 cm, and first primary tumor were associated with improved OS. Tumor grade, tumor size, and surgery were independent predictors of CSS. […] Among patients with primary chondrosarcoma of bone and metastasis at presentation, low tumor grade, surgical treatment, tumor size 10 cm, and first primary tumor predict prolonged survival.

• #95 Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis

  https://www.jcancer.org/v10p2457.htm

  The 5- and 10-year OS rates of the metastatic chondrosarcoma were 28.4% and 22.8%, respectively, while the 5- and 10-year CSS rates were 31.2% and 26.6%. Additionally, the median OS and CSS of our cohort were 14.0 2.5 months and 17.0 2.6 months, respectively, suggesting a pretty poor prognosis. […] Tumor grade was usually recognized as a very important predictor of chondrosarcoma. […] Therefore, tumor grade is an important prognostic factor for chondrosarcoma patients with metastasis, whether at presentation or otherwise. […] Surgical resection of primary tumors significantly prolonged the survival of metastatic chondrosarcoma patients. In patients with metastasis, removing the primary tumor can alleviate pain, improve quality of life, and prolong survival.

• #96 Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis

  https://www.jcancer.org/v10p2457.htm

  The 5- and 10-year OS rates of the metastatic chondrosarcoma were 28.4% and 22.8%, respectively, while the 5- and 10-year CSS rates were 31.2% and 26.6%. Additionally, the median OS and CSS of our cohort were 14.0 2.5 months and 17.0 2.6 months, respectively, suggesting a pretty poor prognosis. […] Tumor grade was usually recognized as a very important predictor of chondrosarcoma. […] Therefore, tumor grade is an important prognostic factor for chondrosarcoma patients with metastasis, whether at presentation or otherwise. […] Surgical resection of primary tumors significantly prolonged the survival of metastatic chondrosarcoma patients. In patients with metastasis, removing the primary tumor can alleviate pain, improve quality of life, and prolong survival.

• #97 Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis

  https://www.jcancer.org/v10p2457.htm

  The 5- and 10-year OS rates of the metastatic chondrosarcoma were 28.4% and 22.8%, respectively, while the 5- and 10-year CSS rates were 31.2% and 26.6%. Additionally, the median OS and CSS of our cohort were 14.0 2.5 months and 17.0 2.6 months, respectively, suggesting a pretty poor prognosis. […] Tumor grade was usually recognized as a very important predictor of chondrosarcoma. […] Therefore, tumor grade is an important prognostic factor for chondrosarcoma patients with metastasis, whether at presentation or otherwise. […] Surgical resection of primary tumors significantly prolonged the survival of metastatic chondrosarcoma patients. In patients with metastasis, removing the primary tumor can alleviate pain, improve quality of life, and prolong survival.

Zobacz więcej